Vergoeding 2020-2024 voor ATC-subgroep B01AF : Directe remmers van factor xa
- Raming voor de totale Zvw-populatie
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| B01AF01 Rivaroxaban (Xarelto ®) | 91.690.000 | 100.546.900 | 112.237.800 | 126.431.000 | 132.136.300 |
| B01AF02 Apixaban (Eliquis ®) | 77.029.200 | 93.343.000 | 113.775.000 | 121.691.900 | 153.899.300 |
| B01AF03 Edoxaban (Lixiana ®) | 23.635.300 | 27.756.200 | 32.297.000 | 39.011.500 | 42.941.200 |
| Totaal | 192.354.500 | 221.646.100 | 258.309.800 | 287.134.400 | 328.976.800 |